Coronavirus disease 2019 in pregnancy

Xu Qiancheng, Shen Jian, Pan Lingling, Huang Lei, Jiang Xiaogan, Lu Weihua, Yang Gang, Li Shirong, Wang Zhen, Xiong GuoPing, Zha Lei, sixth batch of Anhui medical team aiding Wuhan for COVID-19, Xu Qiancheng, Shen Jian, Pan Lingling, Huang Lei, Jiang Xiaogan, Lu Weihua, Yang Gang, Li Shirong, Wang Zhen, Xiong GuoPing, Zha Lei, sixth batch of Anhui medical team aiding Wuhan for COVID-19

Abstract

Objectives: This study aimed to compare clinical courses and outcomes between pregnant and reproductive-aged non-pregnant women with COVID-19, and to assess the vertical transmission potential of COVID-19 in pregnancy.

Methods: Medical records of pregnant and reproductive-aged non-pregnant women hospitalized with COVID-19 from January 15 to March 15, 2020 were retrospectively reviewed. The severity of disease, virus clearance time, and length of hospital stay were measured as the primary objective, while the vertical transmission potential of COVID-19 was also assessed.

Results: Eighty-two patients (28 pregnant women, 54 reproductive-aged non-pregnant women) with laboratory-confirmed COVID-19 were enrolled in this study. Univariate regression indicated no association between pregnancy and severity of disease (OR 0.73, 95% CI 0.08-5.15; p=0.76), virus clearance time (HR 1.16, 95% CI 0.65-2.01; p=0.62), and length of hospital stay (HR 1.10, 95% CI 0.66-1.84; p=0.71). Of the pregnant women, 22 delivered 23 live births, either by cesarean section (17, 60.7%) or vaginal delivery (5, 17.9%), and no neonate was infected with SARS-CoV-2.

Conclusions: Pregnant women have comparable clinical courses and outcomes with reproductive-aged non-pregnant women when infected with SARS-CoV-2. No evidence supported vertical transmission of COVID-19 in the late stage of pregnancy, including vaginal delivery.

Keywords: COVID-19; SARS-CoV-2; clinical feature; infection; pregnancy; virus.

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Figures

Fig. 1
Fig. 1
Flow chart of the study inclusion process.
Fig. 2
Fig. 2
Kaplan-Meier curves and log-rank tests for length of hospital stay and virus clearance time in pregnant and reproductive-aged non-pregnant women with coronavirus disease 2019 (COVID-19).

References

    1. Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet (London, England) 2020;395(10226):809–815.
    1. Chen L., Li Q., Zheng D., Jiang H., Wei Y., Zou L. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. The New England journal of medicine. 2020
    1. Creanga A.A., Johnson T.F., Graitcer S.B., Hartman L.K., Al-Samarrai T., Schwarz A.G. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstetrics and gynecology. 2010;115(4):717–726.
    1. Cucinotta D., Vanelli M. WHO Declares COVID-19 a Pandemic. Acta bio-medica: Atenei Parmensis. 2020;91(1):157–160.
    1. Hiratsuka M., Minakami H., Koshizuka S., Sato I. Administration of interferon-alpha during pregnancy: effects on fetus. Journal of perinatal medicine. 2000;28(5):372–376.
    1. Jamieson D.J., Honein M.A., Rasmussen S.A., Williams J.L., Swerdlow D.L., Biggerstaff M.S. H1N1 2009 influenza virus infection during pregnancy in the USA. 2009;374(9688):0–458.
    1. Lam C.M., Wong S.F., Leung T.N., Chow K.M., Ho L.C. A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome. Bjog An International Journal of Obstetrics & Gynaecology. 2004;111(8):771–774.
    1. Liang H., Acharya G. Novel corona virus disease (COVID-19) in pregnancy: what clinical recommendations to follow? Acta obstetricia et gynecologica Scandinavica. 2020;99(4):439–442.
    1. Liang W., Guan W., Chen R., Wang W., Li J., Xu K. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology. 2020;21(3):335–337.
    1. Liu Y., Chen H., Tang K., Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. The Journal of infection. 2020
    1. Longman R.E., Johnson T.R. Viral respiratory disease in pregnancy. Curr Opin Obstet Gynecol. 2007;19(2):120–125.
    1. Mao R., Liang J., Shen J., Ghosh S., Zhu L.R., Yang H. Implications of COVID-19 for patients with pre-existing digestive diseases. The lancet Gastroenterology & hepatology. 2020
    1. Narayana K., D'Souza U.J., Narayan P., Kumar G. The antiviral drug ribavirin reversibly affects the reproductive parameters in the male Wistar rat. Folia morphologica. 2005;64(2):65–71.
    1. NHFPC . 7th edn. 2020 Mar 04. New coronavirus pneumonia prevention and control program. (accessed Mar 22, 2020; in Chinese). 2020.
    1. Pazos M., Sperling R.S., Moran T.M., Kraus T.A. The influence of pregnancy on systemic immunity. Immunologic Research. 2012;54(1–3):254–261.
    1. Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet (London, England) 2020;395(10226):760–762.
    1. Rasmussen S.A., Jamieson D.J. Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to a Rapidly Evolving Situation. Obstetrics & Gynecology. 2020 Publish Ahead of Print.
    1. Rasmussen S.A., Smulian J.C., Lednicky J.A., Wen T.S., Jamieson D.J. Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know. American journal of obstetrics and gynecology. 2020
    1. Schwartz D.A. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med. 2020
    1. Schwartz D.A., Graham A.L. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses. 2020;12(2)
    1. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020
    1. Wang S., Guo L., Chen L., Liu W., Cao Y., Zhang J. A case report of neonatal COVID-19 infection in China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020
    1. Weetman A.P. Immunity, thyroid function and pregnancy: molecular mechanisms. Nature reviews Endocrinology. 2010;6(6):311–318.
    1. WHO . 2020. Coronavirus disease 2019 (COVID-19) Situation Report. Mar 16, 2020. https://wwwwhoint/docs/default-source/coronaviruse/situation-reports/20200318-sitrep-58-covid-19pdf?sfvrsn = 20876712_2 (accessed Mar 16, 2020)
    1. Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. Jama. 2020
    1. Zeng L., Xia S., Yuan W., Yan K., Xiao F., Shao J. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. JAMA pediatrics. 2020
    1. Zha L., Li S., Pan L., Tefsen B., Li Y., French N. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19) The Medical journal of Australia. 2020
    1. Zhang L., Jiang Y., Wei M., Cheng B.H., Zhou X.C., Li J. [Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province] Zhonghua fu chan ke za zhi. 2020;55(0):E009.
    1. Zhao J., Yuan Q., Wang H., Liu W., Liao X., Su Y. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020
    1. Zhao J.P., Hu Y., Du R.H., Chen Z.S., Jin Y., Zhou M. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2020;43(3):183–184.
    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine. 2020;382(8):727–733.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться